A. I. for Continuous Q. T. Monitoring 01/09/26

Welcome to Cardiology Today – Recorded January 09, 2026. This episode summarizes 5 key cardiology studies on topics like MTEER and transcatheter interventions. Key takeaway: A. I. for Continuous Q. T. Monitoring. Article Links: Article 1: 2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures. (Journal of the American College of Cardiology) Article 2: Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation. (Circulation) Article 3: Air pollution, meteorological factors, and cardiac remodelling in children: a multi-omics cohort study. (European heart journal) Article 4: VENOPULMONARY EXTRACORPOREAL LIFE SUPPORT: AN ELSO REGISTRY ANALYSIS. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 5: Contemporary Operator Procedural Volumes and Outcomes for TAVR and MTEER in the US. (JAMA cardiology) Full episode page: https://podcast.explainheart.com/podcast/a-i-for-continuous-q-t-monitoring-01-09-26/ Featured Articles Article 1: 2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41505788 Summary: C. C. / A. H. A. Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures. The 2026 American College of Cardiology/American Heart Association Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease provide guidance for clinicians, researchers, and quality assurance personnel. These measures establish standards for assessing the effects of treatment decisions, including specific medications and diagnostic tests for individuals with peripheral artery disease. They serve to standardize care and facilitate quality assurance in clinical practice and research for this patient population. Article 2: Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41460938 Summary: T. Monitoring to Identify High-Risk Prolongation Events After Class Three Antiarrhythmic Initiation. A deep learning system called 3DRECON-QT was developed for continuous Q. T. monitoring to identify high-risk Q. T. prolongation events. This system addresses drug-induced Q. T. prolongation that can occur after initiation of class three antiarrhythmics during outpatient care. 3DRECON-QT reconstructs spatial information from a single lead vector to quantify Q. T. and Q. T. corrected intervals. Its development provides a novel approach for identifying high-risk Q. T. prolongation, overcoming limitations of current insertable cardiac monitors. Article 3: Air pollution, meteorological factors, and cardiac remodelling in children: a multi-omics cohort study. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41511488 Summary: A multi-omics cohort study investigates the effects of air pollution and meteorological factors on cardiac remodeling in children. A total of 2029 children were enrolled in the Southwest Health Children Cohort in China to provide crucial data on these exposures. This research illuminates how environmental factors influence cardiovascular structure and function and the underlying biomolecular mechanisms in pediatric populations. The study addresses a critical knowledge gap regarding these effects in children, contrasting with established associations in adults. Article 4: VENOPULMONARY EXTRACORPOREAL LIFE SUPPORT: AN ELSO REGISTRY ANALYSIS. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41506589 Summary: L. S. O. Registry Analysis. This Extracorporeal Life Support Organization registry analysis provides real-world outcomes for adults receiving venopulmonary extracorporeal life support. The study utilized a large sample size from the E. L. S. O. registry to describe patient experiences across various clinical conditions. It establishes data regarding the current use, adverse events, and prognostic drivers for venopulmonary extracorporeal life support, where previous information was limited. Article 5: Contemporary Operator Procedural Volumes and Outcomes for TAVR and MTEER in the US. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41505119 Summary: S. This cohort study investigated...